Latest News & Opportunities
New » Call for Applications: EMVDA Industrial Training Programme | Deadline: 24 Sept. 2010. OPEN
»Access Old Website Here
New » AMANET Annual Report 2009: Click here to read the just released report.
»More News, Opportunities Here
Special Issue .
Read the Acta Tropica Special issue on "Health Research in Africa: Ethical and Practical Challenges".
"Self-sustainable Centers, at International level"
AMANET provides resources and strengthens expertise to empower African malaria research organisations to play a leading role in developing effective interventions tools. The goal is to develop self-sustainable centres that meet international standards. Read more
"Leading Africa in Search of a Malaria Vaccine"
AMANET is proud to be the first and currently the only African organisation to assume sponsor role as far as malaria vaccine trials are concerned. With current control strategies failing, a malaria vaccine will be a major boost in the fight against this scourge. Read more
In 2007, AMANET conducted a baseline survey of 31 ethics review committees in Africa. The survey identifi ed gaps and challenges in the ethical review process in Africa. With this feedback, AMANET is strengthening 20 ERCs through $50,000 subgrants. Read More
Developing a “gold standard” for measuring the malaria specific antibody response to potential candidate vaccines for malaria. AIA networking institutions in Africa are situated in areas with widely differing malaria challenge. Read more
This vaccine is a leading candidate in the AMANET portfolio and has already been shown to be safe in adults in Africa.
Trials on GMZ2 commenced in the second half of 2007 in Gabon. A phase Ib safety trial in adults has been completed. Studies in children ongoing.
Starting in June 2007, this candidate vaccine underwent phase Ib evaluation in adults in Mali. Interim analyses have confirmed its safety.
Copyright © 2010 - All Rights Reserved - amanet-trust.org
Template by OS Templates | Content by Charles Wanga
Funders, Supporters
AMANET is funded by the European Commission’s Directorate-General Research and EuropeAID Cooperation Office (AIDCO), the Danish Development Agency (DANIDA), the Bill and Melinda Gates Foundation, and the European Developing Countries Clinical Trials Partnership (EDCTP). AMANET is highly indebted to the African Caribbean Pacific (ACP) Secretariat for including the network in their portfolio for support.